Evolving trends of reoperative coronary artery bypass grafting: An analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database  by Ghanta, Ravi K. et al.
Acquired Cardiovascular Disease Ghanta et al
A
C
DEvolving trends of reoperative coronary artery bypass grafting:
An analysis of the Society of Thoracic Surgeons Adult Cardiac
Surgery DatabaseRavi K. Ghanta, MD,a Tsuyoshi Kaneko, MD,b James S. Gammie, MD,c Shubin Sheng, PhD,d and
Sary F. Aranki, MDbFrom th
Charl
Harva
of M
Asses
This stu
Hosp
Datab
Disclosu
Read at
Maui
Receive
for pu
Address
Wom
org).
0022-52
Copyrig
for Thor
http://dx
364Objective: The present study evaluated the evolving trends and outcomes of patients undergoing isolated
reoperative coronary artery bypass grafting at Society of Thoracic Surgeons Adult Cardiac Surgery Database–
participating institutions.
Methods: From 2000 to 2009, 72,431 patients underwent isolated reoperative coronary artery bypass grafting
and 1,497,254 patients underwent isolated primary coronary artery bypass grafting at Society of Thoracic Sur-
geons–participating institutions. The demographics, operative characteristics, and risk-adjusted postoperative
outcomes were assessed and compared during the study period.
Results: As a percentage of overall coronary artery bypass grafting volume, reoperative coronary artery bypass
grafting decreased from 6.0% (8820/137,267) in 2000 to 3.4% (5734/160,997) in 2009. The unadjusted oper-
ativemortality declined from 6.1% (542/8820) in 2000 to 4.6% (261/5734) in 2009 (P<.05). Patients nowmore
frequently present with left main disease (35.1% vs 25.7%; P<.05), myocardial infarction (60.9% vs 55.9%;
P < .001), and heart failure (18.4% vs 14.2%; P < .001). Patients also now present more frequently
for urgent or emergent surgery (51.6% vs 39%; P<.001) and after previous percutaneous coronary intervention
(51% vs 35%; P<.001). They also have a greater incidence of other comorbidities such as increased weight
(88 vs 84 kg; P<.001), diabetes (42.5% vs 31.7%; P<.001), hypertension (90.9% vs 73.4%; P<.001),
hypercholesterolemia (90.9% vs 73.4%; P<.001), renal failure (2.2% vs 0.7%; P<.001), and cerebrovascular
disease (12.4% vs 8.5%; P< .001). Risk-adjusted mortality decreased from 6.0% to 4.6%, a relative risk
reduction of 23.7% (P<.001). Risk-adjusted postoperative stroke decreased from 1.9% to 1.6% (P<.001).
Conclusions: Surgical coronary revascularization has evolved during the past decade, with reoperative coronary
artery bypass grafting now uncommonly performed in contemporary practice. Despite treating patients with
more complex coronary artery disease and greater medical comorbidities, significant improvements have
occurred in operative morbidity and mortality in this challenging population. (J Thorac Cardiovasc Surg
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The Journal of Thoracic and Cardiovascular SurgCoronary artery bypass grafting (CABG) remains the refer-
ence standard treatment of patients with complex coronary
artery disease.1-3 We recently analyzed the contemporary
patient characteristics and postoperative outcomes for
1.5 million isolated CABG operations at the Society
of Thoracic Surgeons (STS) Adult Cardiac Surgery
Database–participating institutions.4 In that study, we found
that the risk profiles of patients undergoing isolated CABG
have changed from2000 to 2009,with patients currently pre-
sentingwith a greater number ofmedical comorbidities, such
as diabetes, hypertension, and renal failure. Despite this, sig-
nificant improvements have occurred in morbidity and mor-
tality after isolated CABG during the past decade. In 2009,
the risk-adjusted CABG mortality was 1.7%, representing
a relative risk reduction of 22.8% compared with the risk-
adjusted CABG mortality in 2000. Reoperative CABG in-
volves greater operative complexity and is associated with
greater operative morbidity and mortality than primary
CABG.5 Although patient comorbidities, medical manage-
ment, and percutaneous therapies have evolved, the contem-
porary practice and outcomes of reoperative CABG have notery c February 2013
Abbreviations and Acronyms
ACE ¼ angiotensin-converting enzyme
CABG ¼ coronary artery bypass grafting
IABP ¼ intra-aortic balloon pump
IMA ¼ internal mammary artery
PCI ¼ percutaneous coronary intervention
STS ¼ Society of Thoracic Surgeons
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Dbeen studied. The present study evaluated trends in patient
characteristics and outcomes for patients undergoing iso-
lated reoperative CABG at STS Adult Cardiac Surgery Da-
tabase–participating institutions. We compared these
outcomes over time and with the contemporary primary
CABG outcomes published in our previous study.4MATERIALS AND METHODS
Study Population
The study population consisted of all patients older than 18 years who
underwent isolated primary or reoperative CABG at STS Adult Cardiac
Surgery Database–participating hospitals from January 1, 2000 to Decem-
ber 31, 2009. Patients who underwent isolated reoperative CABG were
those who had undergone previous CABG at any point previously. Patients
were excluded if they had missing data on age, gender, or acuity status.
Data Elements
The STS Adult Cardiac Surgery Database is a clinical database widely
used to assess current clinical practice and outcomes. During the study pe-
riod, STS data definitions and elements changed. For the present study, 4
versions of the STS data collection form were used: version 2.35 for 2000
to 2002, version 2.41 for 2002 to 2004, version 2.52 for 2004 to 2007, and
version 2.61 for 2008 to 2009. Twoversionswere in use simultaneously dur-
ing parts of 2002 and 2004. The definitions for these versions of the STS da-
tabase canbe foundon theSTSwebsite.6All definitionswere reviewedbyus
to determine whether the study variables had comparable definitions over
time. The variables that changed substantially were excluded from the anal-
ysis or were analyzed within shorter periods, during which the definitions
were consistent. The variables that were analyzed during shorter periods
have been appropriately labeled in the tabular data. Variables that hadminor
definitional changes were still used for the analysis. These variables in-
cluded a history of cerebrovascular accident, preoperative arrhythmia, pro-
cedure status, and preoperativemedications. Theminor definitional changes
have been described in detail in our previous study of isolated CABG.4
Study Endpoints
The study endpoints included operative mortality, stroke, renal failure,
prolonged ventilation, deep sternal wound infection, reoperation for bleed-
ing, new postoperative atrial fibrillation, and prolonged length of stay. Op-
erative mortality was defined as death during the same hospitalization as
the surgery or after discharge but within 30 days postoperatively. Stroke
was defined as a central neurologic deficit persisting postoperatively for
longer than 72 hours (database versions 2.35, 2.41, and 2.52) or longer
than 24 hours (database version 2.61). Renal failure was defined as the de-
velopment of a creatinine level greater than 2.0 mg/dL or twice the baseline
level. Prolonged ventilation was defined as pulmonary insufficiency requir-
ing mechanical ventilation for longer than 24 hours postoperatively. Deep
sternal wound infection was defined as a sternal wound with positive
wound culture findings that required antibiotics and incision and drainage.The Journal of Thoracic and CaReoperation for bleeding was defined as an operative reintervention for
bleeding or tamponade. A prolonged length of stay was defined as a postop-
erative hospital stay longer than 14 days.
Statistical Analysis
The statistical analysis has been described in detail in our previous study
of isolated CABG.4 The summary statistics of patient characteristics and
outcomes are presented as the frequency and percentage or median and in-
terquartile range.Differences in patient characteristics across all studyyears
were assessed using the chi-square test for categorical variables and theWil-
coxon rank sum test for continuous variables, with both tests stratified by
STS participant identity. Given the large sample size, P values were not re-
ported because practically every difference would have been statistically
significant but not necessarily clinically significant. Logistic regression
modeling was used to estimate the probability of mortality, stroke, reopera-
tion for bleeding, and prolonged ventilation. We used the general estimated
equation to account for participant variation. Explanatory variables in-
cluded age, gender, body surface area, ejection fraction, dialysis, preopera-
tive atrial fibrillation, shock, immune suppressive treatment, percutaneous
coronary intervention (PCI) within 6 hours, preoperative intra-aortic bal-
loon pump (IABP) or inotrope use, peripheral vascular disease, unstable an-
gina (no myocardial infarction<7 days), left main disease, cerebrovascular
disease, cerebrovascular accident, diabetes, number of diseased vessels,
myocardial infarction status, congestive heart failure/NewYorkHeartAsso-
ciation class, chronic lung disease, and interaction between gender and body
surface area. The risk-adjusted outcomeswere calculated bymultiplying the
year specifically observed to the expected ratio and the outcomes during the
study period. To calculate the statistics of the observed, adjusted outcomes
and the relative risk change, we treated the observed and adjusted outcomes
as a binomial distribution and the expected outcomes as constants.RESULTS
Study Population
From 2000 to 2009, 72,322 patients underwent isolated
reoperative CABG at 1035 STS Adult Cardiac Surgery
Database–participating institutions in the United States.
During the same period 1,497,254 patients underwent
isolated primary CABG. Overall, reoperative CABG consti-
tuted 4.8% (72,322/1,49,254) of the total surgical coronary
revascularization experience.
Figure 1 illustrates the trends in CABG surgery during the
past decade. As a percentage of overall CABG volume, reo-
perative CABG decreased from 6.0% (8820 reoperations vs
137,267 primary; 371 sites) in 2000 to 3.4% (5734 reopera-
tions vs 160,997 primary; 978 sites) in 2009; a 35% reduc-
tion in reoperative CABG volume from 2000 to 2009.Patient Risk Profile
The demographics and risk profiles of patients who un-
derwent primary and reoperative CABG from 2000 to
2009 are compared in Table 1. The primary CABG data
have been previously published but have been included in
the present report to facilitate comparison.4 During the
study period, no significant change occurred in age or gen-
der in the reoperation CABG patients. Racial diversity in-
creased, with fewer white patients in 2009 compared
with 2000 (89% vs 95%). Patient weight (88 vs 84 kg)
and body surface area (2.02 vs 1.98) increased. Medicalrdiovascular Surgery c Volume 145, Number 2 365
FIGURE 1. Incidence of reoperative coronary artery bypass grafting (CABG) during study period.
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Dcomorbidities, such as diabetes (42.5% vs 31.7%), hyper-
cholesterolemia (93.0% vs 71.8%), renal failure (2.2%
vs 0.7%), chronic obstructive pulmonary disease (25.5%
vs 16.6%), hypertension (90.9% vs 73.4%), and cerebro-
vascular disease (12.4% vs 8.5%), were all more prevalent
in 2009 than in 2000. No change was seen in the prevalence
of peripheral vascular disease. A notable decrease has
occurred in smoking from 61.9% of patients in 2000 to
21.6% of patients in 2009.
In 2009, the patients more often presented with conges-
tive heart failure (18.4% vs 14.2%), left main disease
(35.1% vs 25.7%), and myocardial infarction (60.9% vs
55.9%) and had more often undergone previous PCI
(51% vs 35%). In 2009, reoperative CABG was more
likely to be an urgent procedure than elective (51.6% vs
39%). In 2009, more patients were given preoperative
b-blockers, angiotensin-converting enzyme (ACE) inhibi-
tors, and statin medications.
The characteristics of the patients undergoing primary
versus reoperative CABG are also listed in Table 1. In
2009, compared with primary isolated CABG, the reopera-
tive CABG patients were older (67 vs 65 years), more com-
monly men (78.3% vs 72.9%), and more often had diabetes
(42.5% vs 40.4%), hypercholesterolemia (93.0% vs
83.8%), chronic obstructive pulmonary disease (25.5%
vs 22.7%), hypertension (90.9% vs 85.0%), peripheral
vascular disease (22.5% vs 14.7%), and preoperative ar-
rhythmia (13.0% vs 8.6%). Reoperative CABG patients
also presented more often with left main disease (35.1%
vs 31.6%), heart failure (18.4% vs 15.9%), and a lower
ejection fraction (50% vs 55%).
Reoperative CABG Operative Characteristics
The operative characteristics between 2000 and 2009 are
compared in Table 2. An increased prevalence was seen for366 The Journal of Thoracic and Cardiovascular Surgoff-pump reoperative CABG (18% vs 12%) and a decrease
in the use of internal thoracic artery grafting in reoperative
CABG (40% vs 51%) in 2009. The cardiopulmonary
bypass (112 vs 119 minutes) and crossclamp (72 vs 75
minutes) times decreased. A decrease was also seen in
the use of preoperative, intraoperative, and postoperative
IABP.
The operative characteristics of the patients undergoing
primary and reoperative CABG are also listed in Table 2.
In 2009, the use of the internal mammary artery (IMA)
was markedly lower (39.5% vs 94.7%) in the reoperative
CABG patients than in the primary CABG patients. Fewer
procedures were performed off-pump (17.8% vs 21.1%),
with longer perfusion (112 vs 89 minutes) and crossclamp
(72 vs 52 minutes) times. Reoperative CABG patients
more often required IABP placement in the intraoperative
period (6.6% vs 1.5%) than did primary CABG patients.
Morbidity and Mortality
The postoperative observed mortality decreased from
6.1% (542/8820) in 2000 to 4.6% (261/5734) in 2009.
The risk-adjusted mortality decreased from 6.0% to
4.7%. Figure 2 illustrates the observed, predicted, and ad-
justed postoperative mortality for each year during the
study period. A 23.7% reduction occurred in the relative
risk of mortality after reoperative CABG during the study
period (Table 3). Figure 3 illustrates the observed, pre-
dicted, and adjusted postoperative stroke rates for each
year during the study period. The observed stroke rate de-
creased from 1.9% to 1.4%. The risk-adjusted stroke rate
decreased from 1.9% to 1.6%, with a 16.5% relative risk
reduction for stroke. Other complications, such as renal
failure (5.5% vs 4.7%) and deep sternal wound infection
(0.7% vs 0.3%), also decreased during the study period.
No change occurred in the incidence of reoperation forery c February 2013
TABLE 1. Preoperative patient profiles
Variable
Primary CABG Reoperative CABG
2000 (n ¼ 136,513) 2009 (n ¼ 160,997) 2000 (n ¼ 8784) 2009 (n ¼ 5734)
Demographics and risk factors
Age 65 (57-73) 65 (57-73)* 68 (61-74) 67 (61-74)*
Male gender 70.6% 72.9%* 79.5% 78.3%*
White race 92.0% 85.0% 95% 89%
Weight (kg) 84 (73-95) 86 (75-100) 84 (74-95) 88 (76 -100)
BSA 1.97 (1.81-2.12) 2.00 (1.84-2.16) 1.98 (1.84-2.11) 2.02 (1.87-2.17)
Smoker 59.5% 28.0% 61.9% 21.6%
Diabetes 33.4% 40.4% 31.7% 42.5%
Hypercholesterolemia 60.4% 83.8% 71.8% 93.0%
Renal failure with dialysis 1.2% 2.5% 0.7% 2.2%
COPD 16.9% 22.7% 16.6% 25.5%
Hypertension 70.9% 85.0% 73.4% 90.9%
Peripheral vascular disease 14.9% 14.7%* 20.7% 22.5%*
CHF 13.0% 15.9% 14.2% 18.4%
Cerebrovascular disease 5.9% 7.4% 8.5% 12.4%
Arrhythmia 10.0% 8.6% 12.3% 13.0%*
Left main disease 22.6% 31.6% 25.7% 35.1%
Ejection fraction 50 (40-60) 55 (45-60) 50 (40-57) 50 (40-60)
Myocardial infarction 45.4% 46.6% 55.9% 60.9%
Procedure status
Elective 57.6% 41.3% 61% 48.4%
Urgent 38.0% 54.1% 35.8% 48.7%
Emergent 4.2% 4.4% 2.9% 2.9%
Emergent salvage 0.2% 0.2% 0.3% 0.1%
Previous interventions
Preoperative PCI (with or without stent)<6 h 0.8% 0.9%* 1.2% 1.2%*
Any previous PCI (with or without stent) 19.1% 25.6% 35.4% 51.2%
Previous valve surgery 0.2% 0.2% 2.6% 3.5%
Previous other cardiac surgery 1.8% 1.4% 5.3% 4.0%
Preoperative medications
Aspirin 73.1% 79.4%* 77.4% 78.9%*
b Blockers 61.9% 81.4% 66.2% 85.7%
ACE inhibitorsy 38.4% 46.2% 44.1% 51.3%
Statinz 60.6% 64.4% 68.8% 74.2%
Data presented as median (interquartile range) or n (%). CABG, Coronary artery bypass grafting; BSA, body surface area; COPD, chronic obstructive pulmonary disease;
CHF, congestive heart failure; PCI, percutaneous coronary intervention; ACE, angiotensin-converting enzyme. *Not statistically significant change. yData from 2004, not
2000. zData from 2005, not 2000 (primary CABG data published previously).4
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longed length of stay.
The outcomes of primary versus reoperative CABG are
also listed in Table 3. The mortality for reoperative
CABG was 3.5 times that of primary CABG. In addition,
reoperative CABG was associated with increased stroke
(1.9% vs 1.2%), renal failure (5.5% vs 3.2%), reoperation
for bleeding (2.9% vs 2.2%), and deep sternal wound
infection (0.7% vs 0.4%).DISCUSSION
The present study of 72,431 isolated reoperative and
1,497,254 primary CABG patients has identified a number
of important changes in clinical practice during the past de-
cade and has defined the contemporary clinical outcomesThe Journal of Thoracic and Cafrom a large national database. The key finding of the pres-
ent study was that isolated reoperative CABG is now an
uncommon procedure performed in patients withmore com-
plex disease but with significant improvements in morbidity
and mortality during the past decade. The overall mortality
for reoperative CABG, however, remains markedly greater
(3.5 times) than that for primaryCABG.This increasedmor-
tality is likely secondary to the increased comorbidities and
greater operative complexity of reoperative CABG patients.Decline in Reoperative CABG Patient Volume
We have documented a progressive decline in the fre-
quency of reoperative CABG in the practice of surgical cor-
onary revascularization. Reoperative CABG is now an
uncommonly performed operation. As a percentage of therdiovascular Surgery c Volume 145, Number 2 367
TABLE 2. Operative characteristics
Operative characteristics
Primary CABG Reoperative CABG
2000 (n ¼ 136,513) 2009 (n ¼ 160,997) 2000 (n ¼ 8784) 2009 (n ¼ 5734)
Use of IMA 87.7% 94.7% 50.5% 39.5%
Off-pump procedure 14.5% 21.1% 12.2% 17.8%
Perfusion time 92 (72 -116) 89 (69 -113) 119 (92-152) 112 (85-144)
Per distal anastomosis 26 (19-31) 23 (18-30) 31 (24-40) 29 (22-38)
Crossclamp time (min) 61 (45-81) 52 (46-82) 75 (55-99) 72 (52-94)
Per distal anastomosis 17 (12-21) 16 (12-22) 19 (14-26) 18 (13-24)
Distal anastomoses (n)
1 4.7% 4.5% 14.3% 16.9%
2 21.1% 20.5% 22.4% 32.3%
3 73.8% 74.7% 61.0% 50.5%
IABP use
None 91.1% 90.1% 83.3% 85.7%
Preoperative 6.7% 8.1% 7.7% 6.9%
Intraoperative 1.6% 1.5% 7.1% 6.6%
Postoperative 0.4% 0.3% 1.7% 0.8%
Data presented as median (interquartile range) or n (%). CABG, Coronary artery bypass grafting; IMA, internal mammary artery; IABP, intra-aortic balloon pump.
Acquired Cardiovascular Disease Ghanta et al
A
C
Doverall CABG volume, reoperative CABG decreased from
6.0% in 2000 to 3.4% in 2009. Analyzed on a per center
basis, reoperative CABG decreased from 24 cases/center
in 2000 to 6 cases/center in 2009. This decrease has also
been noted in other previous single-center studies.7,8
Spiliotopoulos and colleagues7 found that reoperative
CABG decreased from 7.2% to just 2.2% of the overall
CABG volume from 1990 to 2009 at the Toronto General
Hospital. Similarly, Sabik and colleagues8 found that the re-
operative CABG volume decreased by 50% at the Cleve-
land Clinic from 1990 to 2002.
The reason for the decline in reoperative CABG volume
is unknown; however, we can speculate that improved med-
ical management, expanded usage of PCI for native and sa-
phenous vein graft disease, and increased arterial grafting at
the initial CABG have all likely played a role. Improved
medical therapy with increased use of b-blockers, statins,FIGURE 2. Mortality rate during study period for patients unde
368 The Journal of Thoracic and Cardiovascular Surgand ACE inhibitors can slow the progression of coronary
disease and delay or obviate the need for surgical revascu-
larization.9 In the present study, among patients undergoing
reoperative CABG, more were receiving statin and ACE in-
hibitor therapy in 2009 than in 2004. The emphasis on med-
ical therapy rather than revascularization has also increased
for patients with stable angina, which could have affected
both the PCI and CABG volume.10 Riley and colleagues11
found that PCI usage expanded by 31% from 2001 to
2004 in the US Medicare population. Since 2004, however,
PCI use actually decreased by 20%, likely reflecting clini-
cal trials demonstrating the lack of benefit to adding PCI to
optimal medical therapy for stable coronary artery dis-
ease.10 The expanded role of PCI in the treatment of native
and saphenous vein graft disease has likely also contributed
to the reduced reoperative CABG volume.12 In the present
study, we noted that more patients undergoing reoperativergoing reoperative coronary artery bypass grafting (CABG).
ery c February 2013
TABLE 3. Postoperative mortality and morbidity
Variable
Primary CABG Reoperative CABG
2000 2009 P value Relative risk change 2000 2009 P value Relative risk change
Mortality
Observed 2.4% 1.9 <.001 24.4% (28.7% to 20.1%) 6.1% 4.6% <.001 25.9% (37.9% to 13.9%)
Predicted 2.3% 2.3% 5.3% 5.2%
Adjusted 2.3% 1.7% <.001 22.8% (27.3% to 18.3%) 6.0% 4.6% <.001 23.7% (35.9% to 11.5%)
Stroke
Observed 1.6% 1.2% <.001 26.4% (31.6% to 21.1%) 1.9% 1.4% <.001 22.0% (44.5% to 0.6%)
Predicted 1.3% 1.3% 1.6% 1.5%
Adjusted 1.6% 1.2% <.001 26.4% (31.6% to 21.2%) 1.9% 1.6% <.001 16.5% (39.4% to 6.4%)
Renal failure
Observed 3.5% 3.6% .005 5.5% (1.6% to 9.3%) 5.5% 4.7% <.008 14.7% (28.0% to 1.5%)
Predicted 3.8% 4.0% 5.4% 5.4%
Adjusted 3.2% 3.2% .956 0.1% (4.1% to 3.9%) 5.5% 4.9% <.004 15.4% (28.5% to 2.3%)
Reoperation for bleeding
Observed 2.5% 2.2% <.001 9.2% (13.6% to 4.7%) 2.9% 3.6% .291 22.1% (1.7% to 42.6%)
Predicted 2.5% 2.4% 3.2% 3.1%
Adjusted 2.4% 2.2% .002 7.1% (11.6% to 2.5%) 2.9% 3.7% .085 27.6% (6.8% to 48.5%)
Deep sternal wound infection
Observed 0.6% 0.4% <.001 32.9% (41.8% to 23.9%) 0.6% 0.3% <.001 57.7% (24.8% to 90.7%)
Predicted 0.4% 0.4% 0.5% 0.5%
Adjusted 0.6% 0.4% <.001 37.3% (45.8% to 28.7%) 0.7% 0.3% <.001 59.3% (27.4% to 91.2%)
Atrial fibrillation
Observed 19.8% 21.1% <.001 6.4% (4.9% to 7.8%) 18.7% 19.8% .396 6.3% (1.0% to 13.6%)
Predicted 20.3% 21.2% 19.2% 19.5%
Adjusted 20.0% 20.5% .004 2.2% (0.7% to 3.6%) 19.0% 19.9% .532 4.8% (2.4% to 12.0%)
Prolonged ventilation
Observed 7.6% 10.7% <.01 40.0% (37.3% to 42.7%) 11.9% 16.6% .396 39.6% (29.8% to 49.5%)
Predicted 11.2% 12.0% 14.9% 15.8%
Adjusted 6.5% 8.5% <.001 31.2% (28.3% to 34.1%) 11.6% 15.3% .532 31.4% (22.5% to 41.2%)
Prolonged LOS
Observed 5.0% 5.2% <.01 4.8% (1.7% to 8.0%) 7.5% 7.3% .977 2.9% (14.5% to 8.7%)
Predicted 5.9% 6.1% 7.4% 7.8%
Adjusted 4.5% 4.6% <.01 0.8% (2.5% to 4.1%) 7.8% 7.1% .203 8.5% (19.7% to 2.7%)
CABG, Coronary artery bypass grafting; LOS, length of stay.
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from 35% of patients in 2000 to 53% of patients in
2009). During the past 2 decades, an increased use of arte-
rial grafts has occurred during initial CABG.4 The increased
use of the IMA and other arterial grafts might have led to
improved graft patency and a decreased need for repeat
CABG.13,14 Improved postoperative medical management
after initial revascularization could also have improved
the freedom from reoperation.15
Given the significant decline in reoperative CABG sur-
gery (only 6 cases/center), individual surgeon experience
with CABG is becoming limited. Referral to higher volume
surgeons or centers might be prudent for complex reopera-
tive coronary revascularization.
Evolving Patient Risk Profile and Operative Practice
Both primary and reoperative CABG risk profiles have
changed from 2000 to 2009. The primary CABG patient
risk profiles have been described in our previous study.4The Journal of Thoracic and CaAlthough many surgeons have perceived that their patients
are older, we surprisingly found no statistically significant
change in patient age or gender. The prevalence of a number
of comorbidities was significantly greater in 2009 than in
2000. In general, when analyzing large clinical databases,
one must distinguish clinically significant changes from sta-
tistically significant changes. The increased prevalence of
diabetes, hypercholesterolemia, renal failure, chronic ob-
structive pulmonary disease, and hypertension have all
been substantial and, we believe, of clinical significance. Pa-
tients now weigh 5% (4 kg) more and have a greater body
surface area. Also, a clinically significant greater incidence
was seen for left main disease, myocardial infarction, con-
gestive heart failure, and the need for urgent or emergent op-
erations. However, an impressive decrease has occurred in
smoking prevalence from 62% in 2000 to 22% in 2009.
Taking into account all these data, we believe that reopera-
tive CABG patients now present with significantly more
comorbidities and more complex coronary artery disease.rdiovascular Surgery c Volume 145, Number 2 369
FIGURE 3. Stroke rate during study period for patients undergoing reoperative coronary artery bypass grafting (CABG).
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CABG patients has also evolved significantly. An increase
has occurred in the use of off-pump procedures. Although
IMA graft use has increased in primary CABG, it has de-
creased in reoperative CABG.We hypothesized that this de-
crease in IMA use in reoperative CABG is linked to the
increased IMA use in primary CABG. Because previous by-
pass graft data for reoperative CABG were not included in
the STS database, this hypothesis could not be evaluated.
The modest improvements in perfusion and crossclamp
times and decrease in IABP use might not have been large
enough to result in a clinically significant change.
Contemporary Mortality and Morbidity
Despite patients withmore complex disease, the operative
mortality and morbidity have significantly improved from
2000 to 2009. In the present study, the current risk-
adjusted operative mortality for isolated reoperative CABG
was 4.6%, representing an adjusted relative risk reduction
of operative mortality of 23.7% during the decade. Previous
studies have reported operative mortality for reoperative
CABG ranging from 4.8% to 16.7%.16 More recent studies
have also shown that the operativemortality has significantly
improved.7,8 These results mirror the improvements in
operative mortality for primary isolated CABG, for which
we found that the unadjusted operative mortality had
improved from 2.4% to 1.9% during the same period.4
The operative morbidity has also significantly decreased.
Postoperative stroke occurred in 1.4% of patients in the cur-
rent era, representing a 16.5% adjusted relative risk reduc-
tion during the past decade. Similarly, in our study of
isolated primary CABG, we found a stroke rate of 1.2%.4
Tarakji and colleagues17 evaluated the stroke rate for
45,000 patients who underwent CABG at the Cleveland370 The Journal of Thoracic and Cardiovascular SurgClinic and similarly found that the stroke rate decreased
from 2.6% in 1988 to 1.6% in 2009. In addition, that study
noted decreases in the rate of renal failure and deep sternal
wound infection.
Improvements in Pre-, Intra-, and Postoperative
Management
We believe the improvements in operative mortality and
morbidity during the past decade resulted from a variety of
improvements in the pre-, intra-, and postoperative manage-
ment for patients undergoing reoperative CABG.
In addition to better preoperative medical management,
better preoperative planning using imaging techniques has
likely improved the operative outcomes. Preoperative imag-
ing using computed tomography assists with operative plan-
ning for sternal re-entry, preservation of previous graft
conduits, and cannulation strategies.18,19 Myocardial
viability studies can help identify appropriate targets for
revascularization.20
A number of improvements have been made in intraoper-
ative management and cardiac anesthesia. The increased
use of intraoperative transesophageal echocardiography
and epiaortic scanning might reduce the incidence of
stroke and guide placement of retrograde cardioplegia, pe-
ripheral cannulation, and IABP.21,22 Adequate myocardial
protection during reoperative CABG can be challenging,
particularly in the setting of a patent mammary graft. The
increased use of retrograde cardioplegia and systemic
hyperkalemia aid in achieving diastolic arrest and
myocardial protection.23,24
A number of improvements has occurred in postoperative
management, including the development of dedicated car-
diothoracic intensivists, early extubation protocols, blood
conservation, and glucose control.25,26ery c February 2013
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Despite the improvements, reoperative CABG has
greater risks of operative mortality and morbidity compared
with primary CABG. This is not surprising, given that reo-
perative CABG is performed in older, sicker patients and in-
volves greater technical complexity, with sternal re-entry,
peripheral cannulation, conduit availability, and poor target
vessels. These technical challenges lead to prolonged by-
pass and crossclamp times compared with those for primary
CABG. In addition, patients who require reoperative CABG
likely have more diffuse and earlier onset disease than do
primary CABG patients. These multiple factors are likely
the reason for the 3.5 times increased mortality risk in reo-
perative CABG patients.
Given this increased mortality risk, efforts to avoid re-
quiring reoperative CABG should continue. More arterial
grafting and continued improvements in medical manage-
ment (eg, aspirin, b-blockers, statins) should be empha-
sized. Planning for the second operation should begin at
the primary operation to reduce later mortality and morbid-
ity risk should the patient require a reoperation. Conduits
should be positioned to allow safe sternal re-entry (eg, ap-
propriate localization of the IMA under the upper lobe
and away from the midline). Loose pericardial closure
should also be considered, when feasible.
Study Limitations
The present studywas limited to the information provided
in the STSAdult Cardiac SurgeryDatabase. Because this da-
tabase currently represents 978 institutions performing car-
diac surgery in the United States, the results of this database
are reflective of current clinical practice and generalizable to
the general population. As described in the ‘‘Materials
andMethods’’ section, some database definition changes oc-
curred during the course of the present study. These changes
were minor, and we believe did not affect the validity of our
findings. The STS database is limited only to perioperative
outcomes; thus, we could not draw any conclusions about
the long-term postoperative outcomes. The database does
not contain information regarding the indication for reoper-
ative CABG (eg, progression of native disease, failed vein
graft, failed PCI). We noted a decrease in the use of internal
thoracic arterial grafting in reoperative CABG and hypoth-
esized that was resulted from an increased use of thoracic ar-
terial grafting at primary CABG. Because the STS database
does not capture the conduits used in previous CABG, we
could not evaluate this hypothesis in the present study.
Before July 2011, the database did not capture the interval
between the current and previous operation.
CONCLUSIONS
A decrease has occurred in reoperative CABG surgery
volume in the United States during the past decade. The pa-
tients who do undergo reoperative CABG have moreThe Journal of Thoracic and Cacomplex coronary artery disease and a greater incidence
of medical comorbidities but have improved preoperative
medical management with an increased use of statin and
ACE inhibitor therapy. The operative morbidity and mortal-
ity have also significantly improved. Reoperative CABG
surgery is now performed with an operative mortality of
4.6% and stroke rate of 1.4% in the United States. These
outcomes should serve as benchmarks for competing revas-
cularization therapies for patients who have previously un-
dergone cardiac surgery.References
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